Pinheiro Manuela, Pinto Carla, Peixoto Ana, Veiga Isabel, Lopes Paula, Henrique Rui, Baldaia Helena, Carneiro Fátima, Seruca Raquel, Tomlinson Ian, Kovac Michal, Heinimann Karl, Teixeira Manuel R
Department of Genetics, Portuguese Oncology Institute, Rua Doutor António Bernardino Almeida, 4200-072 Porto, Portugal.
Department of Pathology, Portuguese Oncology Institute, Rua Doutor António Bernardino Almeida, 4200-072 Porto, Portugal.
Br J Cancer. 2015 Aug 11;113(4):686-92. doi: 10.1038/bjc.2015.281. Epub 2015 Aug 6.
We previously reported that the target genes in sporadic mismatch repair (MMR)-deficient colorectal carcinomas (CRCs) in the distal colon differ from those occurring elsewhere in the colon. This study aimed to compare the target gene mutational pattern in microsatellite instability (MSI) CRC from Lynch syndrome patients stratified by tumour location and germline mutation, as well as with that of sporadic disease.
A series of CRC from Lynch syndrome patients was analysed for MSI in genes predicted to be selective MSI targets and known to be involved in several pathways of colorectal carcinogenesis.
The most frequently mutated genes belong to the TGF-β superfamily pathway, namely ACVR2A and TGFBR2. A significantly higher frequency of target gene mutations was observed in CRC from patients with germline mutations in MLH1 or MSH2 when compared with MSH6. Mutations in microsatellite sequences (A)7 of BMPR2 and (A)8 of MSH3 were significantly more frequent in the distal CRC. Additionally, we observed differences in MSH3 and TGFBR2 mutational frequency between Lynch syndrome and sporadic MSI CRC regarding tumour location.
Our results indicate that the pattern of genetic changes differs in CRC depending on tumour location and between Lynch syndrome and sporadic MSI CRC, suggesting that carcinogenesis can occur by different pathways even if driven by generalised MSI.
我们之前报道过,远端结肠散发性错配修复(MMR)缺陷型结直肠癌(CRC)中的靶基因与结肠其他部位出现的靶基因不同。本研究旨在比较林奇综合征患者的微卫星不稳定(MSI)CRC中,按肿瘤位置和种系突变分层的靶基因突变模式,以及与散发性疾病的靶基因突变模式。
对一系列林奇综合征患者的CRC进行分析,检测预测为选择性MSI靶点且已知参与结直肠癌发生的多个途径的基因中的MSI。
最常发生突变的基因属于TGF-β超家族途径,即ACVR2A和TGFBR2。与MSH6相比,在MLH1或MSH2种系突变患者的CRC中观察到靶基因突变频率显著更高。BMPR2的微卫星序列(A)7和MSH3的(A)8中的突变在远端CRC中明显更频繁。此外,我们观察到林奇综合征和散发性MSI CRC在肿瘤位置方面,MSH3和TGFBR2突变频率存在差异。
我们的结果表明,CRC中的基因变化模式因肿瘤位置不同而有所差异,并且在林奇综合征和散发性MSI CRC之间也存在差异,这表明即使由全身性MSI驱动,癌症发生也可能通过不同途径。